Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
Open Access
- 9 March 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 10, 80
Abstract
Folate receptor α (FRα) autoantibodies (FRAAs) are prevalent in autism spectrum disorder (ASD). They disrupt the transportation of folate across the blood-brain barrier by binding to the FRα. Children with ASD with FRAAs have been reported to respond well to treatment with a form of folate known as folinic acid, suggesting that they may be an important ASD subgroup to identify and treat. There has been no investigation of whether they manifest unique behavioral and physiological characteristics. Thus, in this study we measured both blocking and binding FRAAs, physiological measurements including indices of redox and methylation metabolism and inflammation as well as serum folate and B12 concentrations and measurements of development and behavior in 94 children with ASD. Children positive for the binding FRAA were found to have higher serum B12 levels as compared to those negative for binding FRAAs while children positive for the blocking FRAA were found to have relatively better redox metabolism and inflammation markers as compared to those negative for blocking FRAAs. In addition, ASD children positive for the blocking FRAA demonstrated better communication on the Vineland Adaptive Behavior Scale, stereotyped behavior on the Aberrant Behavioral Checklist and Mannerisms on the Social Responsiveness Scale. This study suggests that FRAAs are associated with specific physiological and behavioral characteristics in children with ASD and provides support for the notion that these biomarkers may be useful for subgrouping children with ASD, especially with respect to targeted treatments.Keywords
Funding Information
- Arkansas Biosciences Institute
- Autism Research Institute
- Autism Speaks
This publication has 43 references indexed in Scilit:
- Effectiveness of Methylcobalamin and Folinic Acid Treatment on Adaptive Behavior in Children with Autistic Disorder Is Related to Glutathione Redox StatusAutism Research and Treatment, 2013
- Neuromagnetic Oscillations Predict Evoked-Response Latency Delays and Core Language Deficits in Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2013
- Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brainTranslational Psychiatry, 2012
- Cerebral folate receptor autoantibodies in autism spectrum disorderMolecular Psychiatry, 2012
- A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposuresMolecular Psychiatry, 2011
- Mitochondrial Dysfunction Can Connect the Diverse Medical Symptoms Associated With Autism Spectrum DisordersPediatric Research, 2011
- Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysisMolecular Psychiatry, 2011
- Association between blocking folate receptor autoantibodies and subfertilityFertility and Sterility, 2009
- Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autismThe American Journal of Clinical Nutrition, 2009
- Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006